Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 6 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| TFF Pharmaceuticals, Inc. | 842,095 | reported | 03 Jul 2024 | tx 14+2,774,409 |
| Fortress Biotech, Inc. | 30,000 | reported | 20 Jun 2013 | tx 3+1,716,590 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Jul 2024 | GRANT_AWARD | TFF Pharmaceuticals, Inc. | 27,480 | 0.00 USD | |
| 03 Jul 2024 | GRANT_AWARD | TFF Pharmaceuticals, Inc. | 27,480 | 0.00 USD | deriv |
| 18 Apr 2024 | GRANT_AWARD | TFF Pharmaceuticals, Inc. | 44,967 | 0.00 USD | deriv |
| 15 Aug 2023 | PURCHASE | TFF Pharmaceuticals, Inc. | 600,000 | 0.25 USD | |
| 10 Mar 2023 | PURCHASE | TFF Pharmaceuticals, Inc. | 150,000 | 0.88 USD | |
| 15 Dec 2022 | PURCHASE | TFF Pharmaceuticals, Inc. | 50,000 | 1.06 USD | |
| 03 Dec 2022 | GRANT_AWARD | TFF Pharmaceuticals, Inc. | 1,792,450 | 0.00 USD | deriv |
| 18 May 2022 | PURCHASE | TFF Pharmaceuticals, Inc. | 2,500 | 5.12 USD | |
| 20 May 2022 | PURCHASE | TFF Pharmaceuticals, Inc. | 4,615 | 5.50 USD | |
| 16 May 2022 | PURCHASE | TFF Pharmaceuticals, Inc. | 2,500 | 4.74 USD | first after silence |
| 24 Aug 2020 | GRANT_AWARD | TFF Pharmaceuticals, Inc. | 20,000 | 0.00 USD | deriv |
| 29 Nov 2019 | GRANT_AWARD | TFF Pharmaceuticals, Inc. | 3,623 | 0.00 USD | deriv |
| 25 Oct 2019 | PURCHASE | TFF Pharmaceuticals, Inc. | 5,000 | 5.00 USD | first after silence |
| 29 Oct 2019 | GRANT_AWARD | TFF Pharmaceuticals, Inc. | 43,794 | 0.00 USD | deriv |
| 20 Jun 2013 | PURCHASE | Fortress Biotech, Inc. | 10,000 | 7.59 USD | |
| 14 Jan 2013 | PURCHASE | Fortress Biotech, Inc. | 20,000 | 5.71 USD | |
| 07 Jan 2013 | GRANT_AWARD | Fortress Biotech, Inc. | 1,686,590 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 16 May 2022.